Retrospective Cohort Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Dec 14, 2019; 25(46): 6752-6766
Published online Dec 14, 2019. doi: 10.3748/wjg.v25.i46.6752
Table 1 Characteristics of patients enrolled in this study, n (%)
CharacteristicSEER database
West China Hospital database
MPV- groupMPV+ groupP valueMPV- groupMPV+ groupP value
Sample size, n6825714579110
Sex0.041a0.353
Male3458 (50.7)333 (46.6)368 (63.6)75 (68.2)
Female3367 (49.3)381 (53.4)211 (36.4)35 (31.8)
Age at diagnosis (± SEM)66.4 (± 0.13)65.4 (± 0.38)0.019a58.4 (± 0.41)58.35 (± 0.88)0.998
Tumor diameter0.000a0.003a
≤ 2 cm1232 (18.1)62 (8.7)130 (22.5)12 (10.9)
> 2 cm but ≤ 4 cm4377 (64.1)482 (67.5)373 (64.4)73 (66.4)
> 4 cm1216 (17.8)170 (23.8)76 (13.1)25 (22.7)
Positive lymph nodes0.1610.001a
01900 (27.8)214 (30.0)345 (59.6)46 (41.8)
1-32893 (42.4)311 (43.6)195 (33.7)48 (43.6)
≥ 42032 (29.8)189 (26.5)39 (6.7)16 (14.5)
AJCC 8th stage0.000a0.000a
IA500 (7.3)22 (3.1)89 (15.4)4 (3.6)
IB1162 (17.0)19 (20.9)219 (37.8)31 (28.2)
IIA238 (3.5)43 (6.0)37 (6.4)11 (10.0)
IIB2893 (42.4)311 (43.6)195 (33.7)45 (43.6)
III2032 (29.8)189 (26.5)39 (6.7)16 (14.5)
Perineural invasionN/A0.016a
AbsentN/AN/A165 (28.3)19 (17.3)
PresentN/AN/A415 (71.7)91 (82.7)
Intravascular tumor emboliN/A0.971
AbsentN/AN/A494 (85.3)94 (85.5)
PresentN/AN/A85 (14.7)16 (14.5)
Grade10.6050.984
Well differentiated632 (9.3)59 (8.3)5 (0.9)1 (1.0)
Moderately differentiated3397 (49.8)314 (44.0)215 (38.1)37 (37.4)
Poorly/undifferentiated2489 (36.5)251 (35.1)344 (61.0)61 (61.6)
Unknown307 (4.5)90 (12.6)0 (0.0)0 (0.0)
Margin status2N/A0.000a
R0N/AN/A427 (73.7)61 (55.5)
R1N/AN/A152 (26.3)49 (44.5)
R2N/AN/A0 (0.0)0 (0.0)